Evidence map›Paper›PMID 38921580›Full record

ArticleMarine drugs2024

Multifunctional Cell Regulation Activities of the Mussel Lectin SeviL: Induction of Macrophage Polarization toward the M1 Functional Phenotype.

Yuki Fujii, Kenichi Kamata, Marco Gerdol, Imtiaj Hasan, Sultana Rajia, Sarkar M A Kawsar, Somrita Padma, Bishnu Pada Chatterjee, Mayuka Ohkawa, Ryuya Ishiwata and 12 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Marine drugs, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Yuki FujiiGraduate School of Pharmaceutical Sciences, Nagasaki International University, 2825-7 Huis Ten Bosch, Sasebo 859-3298, Japan.ORCID 0000-0001-6408-9620
Kenichi KamataDepartment of Chemistry, KU Leuven, Celestijnenlaan 200G, 3001 Heverlee, Belgium.ORCID 0000-0003-4344-8473
Marco GerdolDepartment of Life Sciences, University of Trieste, Via Licio Giorgieri 5, 34127 Trieste, Italy.ORCID 0000-0001-6411-0813
Imtiaj HasanDepartment of Microbiology, Faculty of Biological Science, University of Rajshahi, Rajshahi 6205, Bangladesh.ORCID 0000-0002-4715-9022
Sultana RajiaCenter for Interdisciplinary Research, Varendra University, Rajshahi, Rajshahi 6204, Bangladesh.
Sarkar M A KawsarDepartment of Chemistry, Faculty of Science, University of Chittagong, Chittagong 4331, Bangladesh.ORCID 0000-0001-7964-9117
Somrita PadmaDepartment of Oncogene Regulation Chittaranjan National Cancer Institute, 37 S.P. Mukherjee Road, Kolkata 700026, India.ORCID 0000-0001-5698-6604
Bishnu Pada ChatterjeeDepartment of Oncogene Regulation Chittaranjan National Cancer Institute, 37 S.P. Mukherjee Road, Kolkata 700026, India.
Mayuka OhkawaGraduate School of NanoBio Sciences, Yokohama City University, 22-2, Seto, Kanazawa-Ku, Yokohama 236-0027, Japan.
Ryuya IshiwataGraduate School of NanoBio Sciences, Yokohama City University, 22-2, Seto, Kanazawa-Ku, Yokohama 236-0027, Japan.
Suzuna YoshimotoGraduate School of NanoBio Sciences, Yokohama City University, 22-2, Seto, Kanazawa-Ku, Yokohama 236-0027, Japan.
Masao YamadaGraduate School of NanoBio Sciences, Yokohama City University, 22-2, Seto, Kanazawa-Ku, Yokohama 236-0027, Japan.
Namiho MatsuzakiGraduate School of NanoBio Sciences, Yokohama City University, 22-2, Seto, Kanazawa-Ku, Yokohama 236-0027, Japan.
Keita YamamotoGraduate School of NanoBio Sciences, Yokohama City University, 22-2, Seto, Kanazawa-Ku, Yokohama 236-0027, Japan.
Yuka NiimiGraduate School of NanoBio Sciences, Yokohama City University, 22-2, Seto, Kanazawa-Ku, Yokohama 236-0027, Japan.
Nobumitsu MiyanishiGraduate School of Food and Nutritional Sciences, Toyo University, 48-1, Oka, Asaka 351-8510, Japan.ORCID 0000-0001-9632-7195
Masamitsu KonnoNational Institute of Advanced Industrial Science and Technology, Koto-Ku, Tokyo 135-0064, Japan.ORCID 0000-0001-6960-2315
Alberto PallaviciniDepartment of Life Sciences, University of Trieste, Via Licio Giorgieri 5, 34127 Trieste, Italy.ORCID 0000-0001-7174-4603
Tatsuya KawasakiGraduate School of Pharmaceutical Sciences, Nagasaki International University, 2825-7 Huis Ten Bosch, Sasebo 859-3298, Japan.ORCID 0000-0002-5991-6174
Yukiko OgawaGraduate School of Pharmaceutical Sciences, Nagasaki International University, 2825-7 Huis Ten Bosch, Sasebo 859-3298, Japan.
Yasuhiro OzekiGraduate School of NanoBio Sciences, Yokohama City University, 22-2, Seto, Kanazawa-Ku, Yokohama 236-0027, Japan.ORCID 0000-0002-2782-6158
Hideaki FujitaGraduate School of Pharmaceutical Sciences, Nagasaki International University, 2825-7 Huis Ten Bosch, Sasebo 859-3298, Japan.ORCID 0000-0002-4105-4430

Funding

Japan Society for the Promotion of Science 19K06239Japan Society for the Promotion of Science 23K06190Japan Society for the Promotion of Science 23K10950Japan Society for the Promotion of Science 24K08716J-GlycoNet cooperative network 23A15J-GlycoNet cooperative network 24E26
6 · The paper itself

Abstract

SeviL, a galactoside-binding lectin previously isolated from the mussel

Indexed as

BivalviaLectinsMacrophagesAnimalsCell ProliferationCytokinesHumansMicePhenotypeRAW 264.7 CellsSignal TransductionCytokinesLectinsasialo-GM1cell proliferationM1 macrophagemorphological alterationMytilidaeR-type lectinSeviLβ-trefoil folding

Identifiers

PMID38921580
PMCPMC11204705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.